The fact that Gli1 had a stronger impact than Gli2 in NSCLC cell proliferation and survival may be due to the fact that the silencing of Gli1 was slightly more effective than the silencing of Gli2 in our study. The gene discussed is GLI2; the disease is non-small cell lung carcinoma.